# C4 Therapeutics, Inc.: Form SC 13D, filed Oct 16, 2020

- Company: [C4 Therapeutics, Inc.](/companies/cccc.md) (CIK 1662579)
- Form: SC 13D
- Filed: 2020-10-16
- Accepted by EDGAR: Oct 16, 2020, 16:09 ET
- Period: not reported
- Accession: 0001193125-20-271093
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1662579/000119312520271093/d91837dsc13d.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1662579/000119312520271093/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1662579/000119312520271093/d91837dsc13d.htm

Filed Oct 16, 2020.
Source: SEC EDGAR, the filing index for accession 0001193125-20-271093. Last ingested by Listed: Nov 14, 2026, 19:39 ET. No prices; not investment advice.
